Skip to main content
SpringerLink
Log in

Purinrezeptoren als Zielstrukturen in der Arzneimittelforschung

  • Wissenschaft
  • Neue Wirkstoffe
  • Published:
BIOspektrum Aims and scope

Zusammenfassung

Membranständige Purinrezeptoren sind aufgrund der zahlreichen Subtypen und ihrer weiten Verbreitung im Organismus für eine große Bandbreite an medizinischen Indikationen von Interesse.

Abstract

Membrane-localized purine receptors represent a new class of drug targets. Due to the large number of different purine receptor subtypes and their wide distribution in the body they are of interest for a wide range of medical indications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Fredholm BB, IJzerman AP, Jacobson KA et al. (2011) Nomenclature and classification of adenosine receptors - an update. Pharmacol Rev 63:1–34

    Article  PubMed  CAS  Google Scholar 

  2. Brunschweiger A, Müller CE (2006) P2 receptors activated by uracil nucleotides - an update. Curr Med Chem 13:289–312

    Article  PubMed  CAS  Google Scholar 

  3. Xu F, Wu H, Katritch V et al. (2011) Structure of an agonist-bound human A2A adenosine receptor. Science 332:322–327

    Article  PubMed  CAS  Google Scholar 

  4. Müller CE, Jacobson KA (2011) Xanthines as adenosine receptor antagonists. In: Fredholm BB (Hrsg) Methylxanthines. Springer-Verlag, Berlin, Heidelberg, 151–199

    Chapter  Google Scholar 

  5. Müller CE, Jacobson KA (2011) Recent developments in adenosine receptor ligands and their potential as novel drugs. Biochim Biophys Acta 1808:1290–1308

    Article  PubMed  Google Scholar 

  6. Hockemeyer J, Burbiel JC, Müller CE (2004) Multigramscale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure - potential drugs for Parkinson’s disease. J Org Chem 69:3308–3318

    Article  PubMed  CAS  Google Scholar 

  7. Armentero MT, Pinna A, Ferré S et al. (2011) Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson’s disease. Pharmacol Ther DOI: 10.1016/j.pharmthera.2011.07.004

  8. Borrmann T, Hinz S, Bertarelli DCG et al. (2009) 1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specifity. J Med Chem 52:3994–4006

    Article  PubMed  CAS  Google Scholar 

  9. Baqi Y, Atzler K, Köse M et al. (2009) High-affinity, nonnucleotide-derived competitive antagonists of platelet P2Y12 receptors. J Med Chem 52:3784–3793

    Article  PubMed  CAS  Google Scholar 

  10. El-Tayeb A, Qi A, Nicholas RA et al. (2011) Structural modifications of UMP, UDP and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors. J Med Chem 54:2878–2890

    Article  PubMed  CAS  Google Scholar 

  11. Baqi Y, Hausmann R, Rosefort C et al. (2011) Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor. J Med Chem 54:817–830

    Article  CAS  Google Scholar 

  12. von Kügelgen I, Schiedel A, Hoffmann K et al. (2008) Cloning and functional expression of a novel Gi protein-coupled receptor for adenine from mouse brain. Mol Pharmacol 73:469–477

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharma-Zentrum Bonn, Pharmazeutisches Institut, Pharmazeutische Chemie I, Universität Bonn, Bonn, Germany

    Christa E. Müller

Authors
  1. Christa E. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christa E. Müller.

Additional information

Christa E. Müller 1980–1983 Pharmaziestudium an der Universität Tübingen. 1985 Approbation als Apotheker. 1988 Promotion (Dr. rer. nat.). 1989–1992 Postdoktorandenstipendium der DFG; Forschungsaufenthalte an den National Institutes of Health, Bethesda, MD, USA. 1994 Habilitation im Fach Pharmazeutische Chemie. 1994–1998 Professorin (C3) für Pharmazeutische Chemie an der Universität Würzburg. Seit 1998 Professorin (C4) an der Universität Bonn. Mitgründerin und Sprecherin des Pharma-Zentrums Bonn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, C.E. Purinrezeptoren als Zielstrukturen in der Arzneimittelforschung. Biospektrum 17, 645–648 (2011). https://doi.org/10.1007/s12268-011-0103-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12268-011-0103-6

Search

Navigation